BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jun 19, 2006
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Analyst picks & changes
Company Bank Analyst Coverage Opinion Wk chg 6/16 cls
Anadys (ANDS) ThinkEquity Andrew McDonald Price target Sell -24% $6.90
McDonald lowered his target to $7 from $8 after President and CEO Kleanthis Xanthopoulos announced his resignation. He said the move is a "signal of no confidence" in HCV compound ANA975, for which Phase Ib data are expected next quarter.
Encysive (ENCY) Punk Matthew...

Read the full 443 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >